BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update

  Total product sales were $31.2 million in the third quarter of 2017.

  November 2, 2017

   · 

  16 min read
• Business

  Cerus Corporation Reports Third Quarter 2017 Results

  At September 30, 2017, the Company had cash, cash equivalents and short-term investments of $59.6 million compared to $71.6 million at December 31, 2016.

  November 2, 2017

   · 

  11 min read
• Drug Development

  Intersect ENT Announces a Pivotal Study Publication of PROPEL Contour Steroid Releasing Sinus Implant

  The study met its primary efficacy endpoint, demonstrating a previously reported statistically significant 65% relative reduction in the need for post-operative interventions.

  November 2, 2017

   · 

  6 min read
• Biotech Beach

  Puma Biotechnology Secures $100 Million Term Loan From Silicon Valley Bank and Oxford Finance

  Puma received gross proceeds of $50 million from the first tranche of the credit facility upon closing on October 31 and intends to use the funds for general corporate purposes and to further support NERLYNX commercial initiatives.

  November 2, 2017

   · 

  5 min read
• Business

  OvaScience Reports Third Quarter 2017 Financial Results

  As of September 30, 2017, OvaScience had cash, cash equivalents and short-term investments of $75.7 million, compared to $114.4 million as of December 31, 2016.

  November 2, 2017

   · 

  10 min read
• Business

  CONMED Corporation Announces Third Quarter 2017 Financial Results

  For the quarter ended September 30, 2017, reported net income totaled $7.2 million, compared to reported net income of $7.3 million a year ago.

  November 2, 2017

   · 

  16 min read
• 

  Business

  Biogen Poaches Merck Exec to Lead New Marketing Team

  Mr. Guindo brings 27 years of experience in the global pharma industry and has held several leadership positions at Merck.

  November 2, 2017

   · 

  4 min read
• Business

  Invacare Announces Departure of Chief Financial Officer

  Invacare today announced the resignation of Sr. VP and CFO Robert K. Gudbranson, who will be leaving the company to pursue a new opportunity, effective November 26, 2017

  November 2, 2017

   · 

  4 min read
• BioCapital

  Rho to Bring Clinical Trial Proficiency to Multiple Conferences in November

  Rho will showcase its clinical trial expertise at three upcoming conferences: TEDMED, North American Cystic Fibrosis Conference (NACFC), and Human Abuse Liability & Abuse-Deterrent Formulation (HAL).

  November 2, 2017

   · 

  3 min read
• Regeneus Presentation on Japan First Strategy At Ord Minnett

  Regeneus provides the Company’s Presentation on Japan First Strategy at Ord Minnett.

  November 2, 2017

   · 

  1 min read